• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vancomycin pharmacokinetics and dosage requirements in hematologic malignancies.

作者信息

Fernández de Gatta M M, Fruns I, Hernández J M, Caballero D, San Miguel J F, Martínez Lanao J, Domínguez-Gil Hurlé A

机构信息

Department of Pharmacy Practice, Faculty of Pharmacy, University of Salamanca, Spain.

出版信息

Clin Pharm. 1993 Jul;12(7):515-20.

PMID:8354038
Abstract
摘要

相似文献

1
Vancomycin pharmacokinetics and dosage requirements in hematologic malignancies.血液系统恶性肿瘤中万古霉素的药代动力学及剂量需求
Clin Pharm. 1993 Jul;12(7):515-20.
2
Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
Pharmacotherapy. 1994 Mar-Apr;14(2):196-201.
3
Prospective evaluation of a vancomycin dosage guideline for neonates.新生儿万古霉素剂量指南的前瞻性评估。
Clin Pharm. 1991 Feb;10(2):129-32.
4
Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.血液系统恶性肿瘤患者血清万古霉素浓度监测的成本效益分析
Clin Pharmacol Ther. 1996 Sep;60(3):332-40. doi: 10.1016/S0009-9236(96)90060-0.
5
Routine monitoring of serum vancomycin concentrations: can waiting be justified?血清万古霉素浓度的常规监测：等待是否合理？
Clin Pharm. 1987 Aug;6(8):655-8.
6
Influence of pharmacokinetic model on vancomycin peak concentration targets.药代动力学模型对万古霉素峰值浓度目标的影响。
Ther Drug Monit. 1996 Apr;18(2):145-8. doi: 10.1097/00007691-199604000-00006.
7
Vancomycin prophylaxis in cardiac operations: determination of an optimal dosage regimen.
J Thorac Cardiovasc Surg. 1983 Jun;85(6):933-5.
8
Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.接受高通量血液透析患者万古霉素给药方案的充足性
Am J Kidney Dis. 2005 Oct;46(4):681-7. doi: 10.1053/j.ajkd.2005.07.018.
9
Pharmacokinetics of vancomycin when administered during high flux hemodialysis.高通量血液透析期间给予万古霉素的药代动力学。
Clin Nephrol. 1998 Jul;50(1):51-5.
10
Vancomycin population pharmacokinetics in neonates.新生儿万古霉素群体药代动力学
Clin Pharmacol Ther. 2000 Apr;67(4):360-7. doi: 10.1067/mcp.2000.105353.

引用本文的文献

1
Therapeutic Monitoring of Vancomycin Implemented by Eremomycin ELISA.采用埃瑞霉素酶联免疫吸附测定法对万古霉素进行治疗监测。
Antibiotics (Basel). 2024 Nov 25;13(12):1133. doi: 10.3390/antibiotics13121133.
2
Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia.发热性中性粒细胞减少症发生时治疗药物监测替考拉宁的准确性。
Medicina (Kaunas). 2023 Apr 13;59(4):758. doi: 10.3390/medicina59040758.
3
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults.中性粒细胞减少症对成人万古霉素临床药代动力学的影响。
Eur J Clin Pharmacol. 2019 Jul;75(7):921-928. doi: 10.1007/s00228-019-02657-6. Epub 2019 Mar 15.
4
Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT).接受造血干细胞移植（HSCT）患者的万古霉素药代动力学参数
Int J Hematol Oncol Stem Cell Res. 2013;7(4):1-9.
5
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.发热性中性粒细胞减少症的抗菌治疗：药代动力学-药效学考虑。
Clin Pharmacokinet. 2013 Oct;52(10):869-83. doi: 10.1007/s40262-013-0086-1.
6
Management of antimicrobial use in the intensive care unit.重症监护病房抗菌药物管理。
Drugs. 2012 Mar 5;72(4):447-70. doi: 10.2165/11599520-000000000-00000.
7
Augmented renal clearance: implications for antibacterial dosing in the critically ill.增强的肾功能清除：对危重症患者抗菌药物剂量的影响。
Clin Pharmacokinet. 2010;49(1):1-16. doi: 10.2165/11318140-000000000-00000.
8
Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.通过药代动力学/药效学分析优化恶性血液病患者的万古霉素剂量
Clin Pharmacokinet. 2009;48(4):273-80. doi: 10.2165/00003088-200948040-00005.
9
Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies.血液系统恶性肿瘤患者万古霉素的群体药代动力学分析。
Antimicrob Agents Chemother. 2005 Dec;49(12):4934-41. doi: 10.1128/AAC.49.12.4934-4941.2005.
10
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.重症患者的抗菌治疗：对导致药物处置改变和药代动力学变异性的病理生理状况的综述。
Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002.